Dr. Esther E. Lyons, D.O. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 609 N Broad St, Edenton, NC 27932 Phone: 252-482-5805 Fax: 252-482-0158 |
News Archive
Medworxx Solutions Inc. today announced that TELUS Health will now offer customers the Medworxx Patient Flow Platform, enabling health care practitioners to better analyze and monitor patient health in an acute care environment. Comprised of Medworxx Clinical Criteria, Bed Management System, and Forms and Assessments, the platform is available as part of TELUS Health's suite of technology solutions.
Aptuit, Inc. has received CEO Cancer Gold Standard™ accreditation, recognizing the organization's commitment to the health of their employees and family members by certifying their efforts to meet an exceptionally high standard of cancer prevention, screening and care guidelines.
The NASDAQ Stock Market announced today that it will delist the common stock of Anesiva, Inc. Anesiva, Inc.'s stock was suspended on January 06, 2010 and has not traded on NASDAQ since that time. NASDAQ will file a Form 25 with the Securities and Exchange Commission to complete the delisting.
MAXIMUS, a leading provider of government services worldwide, today announced that an extension of its Healthy Families contract was approved by the California's Managed Risk Medical Insurance Board (MRMIB) on September 15, 2010. The five-year extension will begin on January 1, 2011 and is valued at approximately $360.6 million.
OSI Pharmaceuticals, Inc. announced today that the U.S. Patent & Trademark Office has issued a "Notice of Allowance" in OSI's reissue application for U.S. Patent No.5,747,498 (the ‘498) composition of matter patent for Tarceva® (erlotinib). The reissued patent will replace the original ‘498 patent and have the same November 2018 expiration date.
› Verified 6 days ago